WO2021246704A1 - Uv-blocking cosmetic composition having increased uv-blocking efficiency due to heat and uv light - Google Patents
Uv-blocking cosmetic composition having increased uv-blocking efficiency due to heat and uv light Download PDFInfo
- Publication number
- WO2021246704A1 WO2021246704A1 PCT/KR2021/006456 KR2021006456W WO2021246704A1 WO 2021246704 A1 WO2021246704 A1 WO 2021246704A1 KR 2021006456 W KR2021006456 W KR 2021006456W WO 2021246704 A1 WO2021246704 A1 WO 2021246704A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- polymer
- self
- heat
- acrylate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 230000001965 increasing effect Effects 0.000 title claims abstract description 31
- 239000002537 cosmetic Substances 0.000 title claims description 12
- 239000000516 sunscreening agent Substances 0.000 claims description 51
- 230000000475 sunscreen effect Effects 0.000 claims description 47
- 229920000642 polymer Polymers 0.000 claims description 43
- 150000005846 sugar alcohols Polymers 0.000 claims description 37
- 230000000903 blocking effect Effects 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 24
- 239000008346 aqueous phase Substances 0.000 claims description 22
- 229920001577 copolymer Polymers 0.000 claims description 22
- 239000012071 phase Substances 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 16
- 229920006037 cross link polymer Polymers 0.000 claims description 16
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical group CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 12
- 229940047670 sodium acrylate Drugs 0.000 claims description 12
- 239000002562 thickening agent Substances 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 11
- 229940048053 acrylate Drugs 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 10
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 230000006750 UV protection Effects 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 9
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 8
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 7
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 claims description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 229920000058 polyacrylate Polymers 0.000 claims description 5
- -1 polyglycerin-3 Chemical compound 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 4
- 239000012965 benzophenone Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims description 4
- 229960003055 bisoctrizole Drugs 0.000 claims description 4
- 229940114081 cinnamate Drugs 0.000 claims description 4
- 229940105990 diglycerin Drugs 0.000 claims description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 229910044991 metal oxide Inorganic materials 0.000 claims description 4
- 150000004706 metal oxides Chemical class 0.000 claims description 4
- 229940100573 methylpropanediol Drugs 0.000 claims description 4
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 4
- 229940099549 polyglycerin-3 Drugs 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 4
- 229960001860 salicylate Drugs 0.000 claims description 4
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 230000002195 synergetic effect Effects 0.000 claims description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 3
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 3
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 claims description 3
- HEAHZSUCFKFERC-LRVMPXQBSA-N [(2e)-2-[[4-[(z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-LRVMPXQBSA-N 0.000 claims description 3
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 3
- 229960005193 avobenzone Drugs 0.000 claims description 3
- 229960004101 bemotrizinol Drugs 0.000 claims description 3
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 claims description 3
- 229960003747 ecamsule Drugs 0.000 claims description 3
- 235000001727 glucose Nutrition 0.000 claims description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 2
- 229960000655 ensulizole Drugs 0.000 claims description 2
- 230000007423 decrease Effects 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 description 29
- 238000004945 emulsification Methods 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 11
- 239000003995 emulsifying agent Substances 0.000 description 10
- 229960001679 octinoxate Drugs 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000004408 titanium dioxide Substances 0.000 description 8
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 7
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 7
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 7
- 239000004926 polymethyl methacrylate Substances 0.000 description 7
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 6
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 3
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 239000002981 blocking agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 125000001165 hydrophobic group Chemical group 0.000 description 3
- 229940068977 polysorbate 20 Drugs 0.000 description 3
- 201000000849 skin cancer Diseases 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 2
- 229960001063 cinoxate Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 229960004881 homosalate Drugs 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000036561 sun exposure Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- SODXZRVMVYFUDO-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol;propane-1,2,3-triol Chemical compound OCC(O)CO.CC(O)COC(C)CO SODXZRVMVYFUDO-UHFFFAOYSA-N 0.000 description 1
- USNOSXAWMRGURQ-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC.C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC USNOSXAWMRGURQ-UHFFFAOYSA-N 0.000 description 1
- CMDKPGRTAQVGFQ-UHFFFAOYSA-N 2-ethoxyethyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCOCCOC(=O)C=CC1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-UHFFFAOYSA-N 0.000 description 1
- HMUKXWVYIAMION-UHFFFAOYSA-N 2-hexoxyphenol;5-methoxy-4-phenyltriazine Chemical compound CCCCCCOC1=CC=CC=C1O.COC1=CN=NN=C1C1=CC=CC=C1 HMUKXWVYIAMION-UHFFFAOYSA-N 0.000 description 1
- NXEMWFJURMXOLD-UHFFFAOYSA-N 4-phenyl-1h-benzimidazole-2-sulfonic acid Chemical compound C1=CC=C2NC(S(=O)(=O)O)=NC2=C1C1=CC=CC=C1.C1=CC=C2NC(S(=O)(=O)O)=NC2=C1C1=CC=CC=C1 NXEMWFJURMXOLD-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FRGAIZLZPOROJH-BKIJVIAGSA-N [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-3-[2-hydroxy-3-(2-hydroxy-3-octadecanoyloxypropoxy)propoxy]propoxy]oxan-2-yl]methyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COCC(O)CO[C@H]1O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@H]1O FRGAIZLZPOROJH-BKIJVIAGSA-N 0.000 description 1
- WYWZRNAHINYAEF-AWEZNQCLSA-N [(2s)-2-ethylhexyl] 4-(dimethylamino)benzoate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-AWEZNQCLSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- RMBRKBNVOHGEJY-UHFFFAOYSA-N bis(3-docosanoyloxy-2-hydroxypropyl) icosanedioate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCCCC RMBRKBNVOHGEJY-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 238000010428 oil painting Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229960002638 padimate o Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229950000601 roxadimate Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 229940030300 trolamine salicylate Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Definitions
- the present invention relates to a method, composition, use or application for increasing the sun protection efficiency of a sunscreen agent by heat.
- UV rays irradiated from sunlight act as a major cause of erythema, edema, freckles, or skin cancer on the skin.
- UV rays are classified according to their wavelength, with a wavelength of 200-280 nm being UV-C, a wavelength of 280-320 nm being UV-B, or a wavelength of 320-400 nm being UV-A.
- UV-C passes through the ozone layer and is lost without reaching the earth's surface.
- UV-A is known to penetrate into the dermis of the skin and cause skin cancer, wrinkles, and melanin formation, thereby causing skin aging and skin irritation. Numerous epidemiological studies have demonstrated a strong relationship between sun exposure and human skin cancer.
- an inorganic UV blocker such as titanium dioxide or zinc oxide, or ethylhexyl methoxycinnamate, ethylhexyl salicylate, octocrylene, butylmethoxydibenzoylmethane, bis-ethyl
- organic UV blocking agents such as hexyloxyphenol methoxyphenyltriazine or diethylaminohydroxybenzoylhexylbenzoate.
- the sunscreen applied to the skin has a problem in that it cannot fulfill its role due to damage to the shielding film by moisture and deterioration of photostability by ultraviolet rays.
- ethylhexyl methoxycinnamate, isoamyl p-methoxycinnamate, or cinoxate which are sunscreens having a methoxycinnamate structure, have a lower efficiency of absorbing light in the ultraviolet region as the trans structure is changed to a cis structure by ultraviolet rays. Falling problems are known.
- UV blocking efficiency is lowered by heat, UV rays cannot be effectively blocked, which can lead to skin aging or various skin diseases.
- the amount of time that the skin is exposed to sunlight increases with the increase in outdoor activities, it may cause inconvenience of having to reapply UV-blocking cosmetics several times.
- the inventors of the present invention showed that when a combination of a polymer having self-emulsifying ability and a polyalcohol having an IOB value of 5.0 or less is used, the UV blocking efficiency of the UV blocker is improved when heat is applied. Rather, a growing number of surprising discoveries have led to the completion of the present invention.
- Embodiment 1 A method of increasing the UV blocking efficiency of a UV blocking agent by heat using a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less.
- Embodiment 2 The method according to Embodiment 1, wherein the method comprises the steps of: preparing an aqueous phase comprising the self-emulsifying polymer and the polyhydric alcohol; preparing an oil phase containing the sunscreen; mixing the aqueous phase part and the oil phase part to prepare a mixed composition; and applying heat to the mixed composition.
- Embodiment 3 A composition for increasing the UV blocking efficiency of a UV blocker by heat, comprising as an active ingredient a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less; Use of a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less to increase the UV protection efficiency of a UV blocker by heat; Or application of a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less for the manufacture of cosmetics in which the blocking efficiency is increased by heat.
- Embodiment 4 The active ingredient according to any one of the preceding embodiments, wherein the active ingredient, which serves to increase the ultraviolet blocking efficiency of the sunscreen by heat, comprises (a) a polymer having self-emulsifying ability and (b) an IOB value of 5.0 A method, composition, use or application, characterized in that it consists of a combination of the following polyhydric alcohols.
- Embodiment 5 The polymer according to any one of the preceding embodiments, wherein the self-emulsifying polymer is a sodium acrylate/behenes-25 methacrylate crosspolymer, a sodium acrylate/sodium acryloyldimethyltaurate copolymer.
- Sodium acrylate / acryloyl dimethacrylate / dimethyl acrylamide cross polymer sodium polyacrylate, acrylate / C10-30 alkyl acrylate cross polymer, acrylate / Behenes-25 methacrylate copolymer, acrylic Late copolymer, ammonium acryloyl dimethyl taurate / Behenes-25 methacrylate cross polymer, ammonium acryloyl dimethyl taurate / VPicopolymer, polyacrylate-13, polyacrylate cross polymer-6, polyacrylic A method, characterized in that at least one selected from the group consisting of amide, PEG-240/H diicopolymer bis-decyltetradeceth-20 ether, and hydroxyethyl acrylate/sodium acryloyldimethyltaurate copolymer , composition, use or application.
- Embodiment 6 The polyalcohol according to any one of the preceding embodiments, wherein the polyalcohol having an IOB value of 5.0 or less is glycerin, sorbitol, xylitol, glucose, trehalose, diglycerin, propanediol, propylene glycol, polyglycerin-3, from the group consisting of methylpropanediol, butylene glycol, pentylene glycol, PEG-6, PEG-8, glycereth-26, dipropylene glycol, 1,2-hexanediol and caprylyl glycol
- IOB value of 5.0 or less is glycerin, sorbitol, xylitol, glucose, trehalose, diglycerin, propanediol, propylene glycol, polyglycerin-3, from the group consisting of methylpropanediol, butylene glycol, pentylene glycol, PEG-6, P
- Embodiment 7 The sunscreen according to any one of the preceding embodiments, wherein the sunscreen is an aminobenzoic acid-based compound, a benzophenone-based compound, a cinnamate-based compound, or a salicylate.
- the sunscreen is an aminobenzoic acid-based compound, a benzophenone-based compound, a cinnamate-based compound, or a salicylate.
- Embodiment 8 The method, composition, use or application according to any one of the preceding embodiments, wherein the self-emulsifying polymer is an aqueous phase thickener.
- Embodiment 9 The composition according to any one of the preceding embodiments, wherein the composition comprises an aqueous phase part and an oil phase part, and (a) a polymer having self-emulsifying ability and (b) a polyalcohol having an IOB value of 5.0 or less is the aqueous phase part It is included in the method, composition, use or application, characterized in that the sunscreen is included in the oil phase.
- Embodiment 10 The method, composition, use or application according to any one of the preceding embodiments, wherein the composition further increases the synergistic effect of the UV blocking efficiency of the UV blocking agent by heat upon UV irradiation.
- Embodiment 10 A cosmetic comprising the composition according to any one of the preceding embodiments.
- One aspect of the present invention is to provide a method for increasing the sunscreen efficiency of a sunscreen by heat using a combination of (a) a self-emulsifying polymer and (b) a polyhydric alcohol having an IOB value of 5.0 or less.
- the method comprises the steps of preparing an aqueous phase comprising the above-described self-emulsifying polymer and polyhydric alcohol; Preparing an oil phase containing the above-described sunscreen; mixing the aqueous phase part and the oil phase part to prepare a mixed composition; and applying heat to the mixed composition.
- compositions for increasing the UV protection efficiency of a UV blocker by heat comprising a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less as an active ingredient will do
- the self-emulsifying polymer (SEP) of the present invention means a polymer that has both a hydrophilic and a hydrophobic group in the chain and thus has an emulsifying ability and a thickening ability at the same time. It is possible to produce a stable composition without a separate emulsifier, and when heat is applied after application, the sunscreen film can be spread, resulting in a wide and uniform UV-blocking area due to heat, thereby increasing the effect. . On the other hand, in the case of general emulsification, even when heat is applied, the emulsifier located at the interface interferes with the movement of the sunscreen, so there is no change in the blocking effect before and after heating. Compared with this general emulsification, the principle of synergy of the UV protection effect by the polymeric emulsification of the present invention is briefly shown in FIG. 1 .
- polymer having self-emulsifying ability examples include sodium acrylate/behenes-25 methacrylate crosspolymer, sodium acrylate/sodium acryloyldimethyltaurate copolymer, sodium acrylate/acryloyldimethacrylate/dimethacrylate.
- Methylacrylamide crosspolymer sodium polyacrylate, acrylate/C10-30 alkyl acrylate crosspolymer, acrylate/behenes-25 methacrylate copolymer, acrylate copolymer, ammonium acryloyldimethyltaurate/behe Ness-25 methacrylate cross polymer, ammonium acryloyl dimethyl taurate/vpicopolymer, polyacrylate-13, polyacrylate crosspolymer-6, polyacrylamide, PG-240/H diicopolymer bis- Decyltetradeceth-20 ether, hydroxyethyl acrylate / sodium acryloyl dimethyl taurate copolymer, etc., but are not limited thereto.
- the self-emulsifying polymer may be included in an amount of 0.01 wt% to 10 wt% in the composition of the present invention.
- the IOB (inorganic-organic balance) value is a numerical value indicating the hydrophilicity of an organic compound, and the higher the value, the higher the hydrophilicity.
- the composition according to the present invention has a viscosity of 1,000 cps or less, more preferably 500 cps or less (measurement conditions: Brookfield viscometer, 40°C, LVF spindle#1, 30rpm, 1 min) of the oil phase.
- the viscosity of the oil component among the components blended in the oil phase is preferably 1,000 cps or less, more preferably 500 cps or less (measurement conditions: Brookfield viscometer, 40° C., LVF spindle#1, 30 rpm, 1 min).
- Polyhydric alcohols having an IOB value of 5.0 or less used in the present invention include, for example, glycerin, sorbitol, xylitol, glucose, trehalose, diglycerin, propanediol, propylene glycol polyglycerin-3, methylpropanediol, butylene glycol, It may be one or more selected from the group consisting of pentylene glycol PEG-6, PEG-8, glycereth-26, dipropylene glycol, 1,2-hexanediol, and caprylyl glycol, but is not limited thereto. .
- the polyalcohol having an IOB value of 5.0 or less may be included in an amount of 0.1 wt% to 50 wt% in the composition of the present invention.
- sunscreens can be used regardless of the type of both organic sunscreens having a UV absorbing effect and inorganic sunscreens having a scattering effect.
- Examples of the aminobenzoic acid-based compound include PABA, glyceryl PABA, Padimate O, Roxadimate, and the like
- examples of the benzophenone-based compound include deoxybenzone. (Dioxybenzone), oxybenzone, sulisonbenzone, etc.
- examples of the cinnamate-based compound include octocrylene, octyl methoxycinnamate (octinoxate), deoxy Ethoxyethyl p-methoxycinnamate (cinoxate), and the like
- examples of the salicylate-based compound include Homomenthyl salicylate (homosalate), Ethylhexyl salicylate (octyl salicylate/octisalate)), trolamine salicylate, and the like
- the inorganic metal oxides include, but are not limited to, titanium dioxide or zinc oxide.
- the sunscreen agent may be included in 0.5 wt% to 30 wt% in the composition of the present invention.
- the active ingredient which serves to increase the UV blocking efficiency of the UV blocker by heat, includes (a) a polymer having self-emulsifying ability and (b) a polyalcohol having an IOB value of 5.0 or less. It may be made up of a combination of
- the composition for increasing the ultraviolet blocking efficiency of a sunscreen by heat of the present invention may include an aqueous phase and an oil phase, wherein the self-emulsifying polymer is an aqueous phase thickener, and the IOB value It is included in the aqueous phase together with 5.0 or less polyhydric alcohol, and the sunscreen may be included in the oil phase.
- the composition for increasing the sunscreen efficiency of a sunscreen by heat of the present invention is dextrin palmitate, disteadimonium hectorite, stearoyl inulin, polyamide-8, glyceryl behenate/eico It may be one that does not substantially contain an oily thickener such as sadioate.
- 'substantially not containing an oil phase thickener' means that the viscosity of the oil phase part is 1,000 cps or less, more preferably 500 cps or less (measurement conditions: Brookfield viscometer, 40 °C, LVF spindle#1, 30 rpm, 1 min) can be included in less than that amount. This is to facilitate the diffusion of the composition components into the pores generated when the aqueous phase volatilizes after the composition according to the present invention is applied to the skin.
- composition for increasing the UV blocking efficiency of the UV blocker by heat of the present invention may not contain an emulsifier component other than the self-emulsifying polymer of the present invention.
- composition of the present invention may further include a moisturizing agent, a thickener, a surfactant, an oily agent, a preservative, an antioxidant, alcohol, a fragrance, a pH adjuster or a natural extract, but is not limited thereto.
- a moisturizing agent preferably 1,000 cps or less, more preferably 500 cps or less (measurement conditions: Brookfield viscometer, 40°C, LVF spindle#1, 30rpm, 1 min) is preferred.
- sunscreens reduce their sunscreen efficiency due to heat, but when using the active ingredient of the present invention, that is, a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less, it is rather caused by heat.
- the UV-blocking efficiency of the sunscreen is increased.
- the SPF value is significantly increased after applying heat of 40° C. for 15 minutes, specifically, at least 1%, at least 5% compared to before the application of heat , at least 10%, at least 15%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 100%, at least 110%, at least 120%, at least 130%, at least 140%, at least 150%, at least 160%, at least 170%, at least 180%, at least 190%, at least 200%, at least 210%, at least 220%, at least 230%, at least 240% , at least 250%, at least 260%, at least 270%, at least 280%, at least 290%, at least 300%, at least 310%, at least 320%, at least 330%, at least 340%, at least 350%, at least 360%, at least It may increase by 370%, at least 380%, or at least 390%,
- composition of the present invention exhibits a synergistic effect with respect to an increase in UV blocking efficiency when UV irradiation is added in addition to heat.
- Another aspect of the present invention is to provide a cosmetic comprising a composition for increasing the UV blocking efficiency of the UV blocker by the above-described heat.
- the cosmetic may be prepared in any formulation conventionally prepared in the art, for example, to be formulated as a solution, suspension, emulsion, paste, gel, cream, lotion, soap, surfactant-containing cleansing, oil, etc.
- the present invention is not limited thereto.
- the cosmetics include mist, serum, nourishing lotion, softening lotion, soft water, emulsion, astringent, toner, skin, lotion, cream, foam, makeup base, essence, liquid detergent, bathing agent, sunscreen cream, sunscreen Oil, sunscreen emulsion, sunblock product, makeup product, makeup base, foundation, makeup pact, BB cream, CC cream, makeup powder, etc.
- the cosmetic, cosmetic, or composition according to the present invention contains the ingredients according to the present invention within the content limit allowed by the relevant laws and regulations of each country.
- the UV blocking efficiency of a sunscreen is reduced by heat, but the present invention provides a technique for rather increasing the UV blocking efficiency of the sunscreen by heat.
- 1 is a schematic view showing the principle of increasing the UV blocking effect by the polymeric emulsification of the present invention compared to the general emulsification.
- the emulsifier located at the interface prevents the movement of the sunscreen, so there is no change in the blocking effect before and after heating. Therefore, it does not interfere with the movement of the sunscreen, and the UV blocking area expands after heating, increasing the blocking effect.
- FIG. 2 is a schematic diagram showing the action of a polyhydric alcohol having an IOB value of 5.0 or less of the present invention. If there is no polyol in the aqueous phase, the sunscreen does not expand when the aqueous phase is completely dried and heated after drying. However, if there is polyol in the aqueous phase, polyol remains in the aqueous phase even after drying Due to the compatibility between polyol and the sunscreen, it is possible to expand the sunscreen to the water phase during heating, increasing the blocking effect.
- 3 is a graph showing the results of evaluating the effect of polymeric emulsification and general emulsification on the UV blocking effect.
- the composition was prepared as shown in Table 2 below and applied to the PMMA plate. After application of each sunscreen composition, the initial in vitro SPF was measured after drying at room temperature for 15 minutes. Thereafter, after heating in a thermostat at 40° C. for 15 minutes, the late in vitro SPF was measured to calculate the rate of change of the initial value and the late value, and the results are shown in FIG. 3 .
- the experimental sample was applied to a PMMA plate (HelioScreen Labs, HD6) at 1.3 mg/cm 2 , dried at room temperature for 15 minutes, and the initial in vitro SPF was measured using SPF-290AS (Solar light, USA). In vitro SPF was measured in 6 different parts of the PMMA plate and the average value was used. Thereafter, the PMMA plate having the initial in vitro SPF measured was placed on a hot plate set at 40°C in advance, heated for 15 minutes, and then the late in vitro SPF was measured to calculate the rate of change between the initial value and the late value.
- Example 15 Example 16
- Example 17 Example 18
- Example 20 Example 21 Prime Minister Purified water to 100 to 100 to 100 to 100 to 100 to 100 to 100 glycerin 10 dipropylene glycol 10 PEG-6 10 PEG-8 10 propanediol 10 5 Butylene Glycol 10 5 Polyacrylate-13 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Ammonium acryloyl dimethyl taurate/vpicopolymer 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 paid part Ethylhexylmethoxycinnamate 6.8 6.8 6.8 6.8 6.8 6.8 6.8 6.8 6.8 Diethylaminohydroxybenzoylhexylbenzoate 4 4 4 4 4 4 4 4 4 4 4 4 Bis-ethy
- a UV protection composition was prepared as shown in Table 7 below and the SPF change rate was calculated after heating. Specifically, each UV blocking composition was applied to a PMMA plate and dried for 15 minutes, and the initial in vitro SPF was measured. Then, after heating in a 40°C thermostat for 15 minutes, the late in vitro SPF was measured, and the SPF change rate compared to the initial value was calculated, and the results are shown in Tables 7 and 5 below.
- the self-emulsifying polymer of the present invention is included in the aqueous phase as an aqueous thickener. Accordingly, it was attempted to prepare a sunscreen composition using an oily thickener instead of the self-emulsifying polymer of the present invention, but in this case, it was confirmed that the stability of the formulation was greatly reduced. Thus, the effect of the polymer having self-emulsifying ability of the present invention was compared with that of the case where an oily thickener was additionally included in the aqueous thickener, and the results are shown in Table 8 below.
- composition 1 composition 2 composition 3 composition 4 composition 5 composition 6 Prime Minister Purified water To 100 To 100 To 100 To 100 To 100 To 100 To 100 To 100 To 100 To 100 To 100 propanediol 5 5 5 5 5 5 5 5 5 Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 Polyacrylate crosspolymer-6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 paid part Ethylhexylmethoxycinnamate 6.8 6.8 6.8 6.8 6.8 6.8 6.8 6.8 6.8 6.8 6.8 Diethylaminohydroxybenzoylhexylbenzoate 4 4 4 4 4 4 4 4 4 4 4 4 Bis-ethylhexyloxyphenol methoxyphenyltriazine 3 3 3 3 3 3 3 3 3 3 3 3 C12-15 Alkylbenzoate 8 8 8 8 8 8 8 Dextrin Palmitate One Disteadimonium Hectorite One Ste
- compositions 2 to 6 As a result of the experiment, it was confirmed that the SPF increase rate was significantly reduced when various oil thickeners were added to Composition 1, which was prepared only with a polymer having self-emulsifying ability (Compositions 2 to 6).
- Table 9 shows the results of confirming the in vitro SPF change according to the temperature when the sunscreen composition (composition 1) of the present invention is exposed to ultraviolet rays.
- the experimental sample was applied to a PMMA plate (HelioScreen Labs, HD6) at 1.3 mg/cm 2 , dried at room temperature for 15 minutes, and the initial in vitro SPF was measured using SPF-290AS (Solar light, USA). Thereafter, the PMMA plate having the initial in vitro SPF measured was placed on a hot plate at a preset temperature and maintained for 15 minutes, and then the late in vitro SPF was measured to calculate the rate of change between the initial and late values. At this time, using a UV irradiator (16S-300, Solar light), the in vitro SPF change rate according to the presence or absence of 2MED UV irradiation was confirmed.
- a UV irradiator (16S-300, Solar light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
원료명Raw material name | OVOV | IVIV | IOBIOB |
글리세린glycerin | 6060 | 300300 | 5.005.00 |
솔비톨sorbitol | 120120 | 600600 | 5.005.00 |
자일리톨 |
100100 | 500500 | 5.005.00 |
글루코스glucose | 120120 | 530530 | 4.424.42 |
트레할로스Trehalose | 240240 | 880880 | 3.673.67 |
디글리세린diglycerin | 120120 | 420420 | 3.503.50 |
프로판디올propanediol | 6060 | 200200 | 3.333.33 |
폴리글리세린-3Polyglycerin-3 | 180180 | 540540 | 3.003.00 |
메칠프로판디올Methylpropanediol | 7070 | 200200 | 2.862.86 |
에탄올ethanol | 4040 | 100100 | 2.502.50 |
부틸렌글라이콜Butylene Glycol | 8080 | 200200 | 2.502.50 |
피이지-6PEG-6 | 240240 | 575575 | 2.402.40 |
피이지-8PEG-8 | 320320 | 725725 | 2.272.27 |
글리세레스-26Glyceres-26 | 180180 | 360360 | 2.002.00 |
디프로필렌글라이콜dipropylene glycol | 120120 | 220220 | 1.831.83 |
1,2-헥산디올1,2-Hexanediol | 120120 | 200200 | 1.671.67 |
성분명Ingredient name | 폴리머릭 유화polymeric emulsification | 일반유화general oil painting | |
수상부Prime Minister | 정제수Purified water | To 100To 100 | To 100To 100 |
부틸렌글라이콜Butylene Glycol | 66 | 66 | |
프로판디올propanediol | 55 | 55 | |
1,2-헥산디올1,2-Hexanediol | 1.51.5 | 1.51.5 | |
폴리아크릴레이트-13Polyacrylate-13 | 0.40.4 | -- | |
하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer | 0.20.2 | -- | |
암모늄아크릴로일디메틸타우레이트/브이피코폴리머Ammonium acryloyl dimethyl taurate/vpicopolymer | 0.20.2 | -- | |
폴리소르베이트20(tween 20)/유화제Polysorbate 20 (tween 20) / Emulsifier | -- | 1One | |
카보머Carbomer | -- | 0.30.3 | |
유상부paid part | 에틸헥실메톡시신나메이트Ethylhexylmethoxycinnamate | 6.86.8 | 6.86.8 |
디에틸아미노하이드록시벤조일헥실벤조에이트Diethylaminohydroxybenzoylhexylbenzoate | 44 | 44 | |
비스-에틸헥실옥시페놀메톡시페닐트리아진Bis-ethylhexyloxyphenol methoxyphenyltriazine | 44 | 44 | |
C12-15 알킬벤조에이트C12-15 Alkylbenzoate | 88 | 88 | |
티타늄디옥사이드titanium dioxide | 2.452.45 | 2.452.45 | |
알루미늄스테아레이트aluminum stearate | 0.420.42 | 0.420.42 | |
폴리하이드록시스테아릭애씨드polyhydroxystearic acid | 0.350.35 | 0.350.35 | |
알루미나alumina | 0.140.14 | 0.140.14 | |
사이클로펜타실록산Cyclopentasiloxane | 1.51.5 | 1.51.5 | |
실리카silica | 1One | 1One | |
디메치콘dimethicone | 22 | 22 | |
트리실록산Trisiloxane | 1.51.5 | 1.51.5 | |
총합total | 100100 | 100100 | |
In vitro SPF 변화율 (%)In vitro SPF change (%) | 269.58269.58 | 2.762.76 |
원료명Raw material name | 비교예1Comparative Example 1 | 실시예1Example 1 | 실시예2Example 2 | 실시예3Example 3 | 실시예4Example 4 | 실시예5Example 5 | 실시예6Example 6 | 실시예7Example 7 | |
수상부Prime Minister | 정제수Purified water | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 |
부틸렌글라이콜Butylene Glycol | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | |
프로판디올propanediol | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | |
1,2-헥산디올1,2-Hexanediol | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | |
카보머Carbomer | 0.30.3 | ||||||||
폴리소르베이트 20Polysorbate 20 | 1One | ||||||||
아크릴레이트/C1O-30알킬아크릴레이트크로스폴리머Acrylate/C1O-30 alkyl acrylate crosspolymer | 1One | ||||||||
피이지-240/에이치디아이코폴리머비스-데실테트라데세스-20에터PEG-240/HDI Copolymer bis-decyltetradeceth-20 ether | 1One | ||||||||
소듐폴리아크릴레이트Sodium Polyacrylate | 1One | ||||||||
암모늄아크릴로일디메틸타우레이트/브이피코폴리머Ammonium acryloyl dimethyl taurate/vpicopolymer | 1One | ||||||||
암모늄아크릴로일디메틸타우레이트/베헤네스-25메타크릴레이트크로스폴리머Ammonium acryloyl dimethyl taurate / Behenes-25 methacrylate crosspolymer | 1One | ||||||||
폴리아크릴레이트크로스폴리머-6Polyacrylate crosspolymer-6 | 1One | ||||||||
하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer | 1One | ||||||||
유상부paid part | 에틸헥실메톡시신나메이트Ethylhexylmethoxycinnamate | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 |
디에틸아미노하이드록시벤조일헥실벤조에이트Diethylaminohydroxybenzoylhexylbenzoate | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | |
비스-에틸헥실옥시페놀메톡시페닐트리아진Bis-ethylhexyloxyphenol methoxyphenyltriazine | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
C12-15 알킬벤조에이트C12-15 Alkylbenzoate | 88 | 88 | 88 | 88 | 88 | 88 | 88 | 88 | |
티타늄디옥사이드titanium dioxide | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
사이클로펜타실록산Cyclopentasiloxane | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | |
디메치콘dimethicone | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
실리카silica | 1One | 1One | 1One | 1One | 1One | 1One | 1One | 1One | |
총합 |
100100 | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | |
in vitro SPF 변화율(%)In vitro SPF change (%) | -0.13-0.13 | 7.147.14 | 9.879.87 | 22.8422.84 | 30.3730.37 | 28.1828.18 | 46.8946.89 | 16.316.3 |
원료명Raw material name | 실시예8Example 8 | 실시예9Example 9 | 실시예10Example 10 | 실시예11Example 11 | 실시예12Example 12 | 실시예13Example 13 | 실시예14Example 14 | |
수상부Prime Minister | 정제수Purified water | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 |
부틸렌글라이콜Butylene Glycol | 55 | 55 | 55 | 55 | 55 | 55 | 55 | |
프로판디올propanediol | 55 | 55 | 55 | 55 | 55 | 55 | 55 | |
1,2-헥산디올1,2-Hexanediol | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | |
폴리아크릴레이트-13Polyacrylate-13 | 1One | |||||||
폴리아크릴아마이드polyacrylamide | 1One | |||||||
아크릴레이트코폴리머acrylate copolymer | 1One | |||||||
아크릴레이트/베헤네스-25메타크릴레이트코폴리머Acrylate/Behenes-25 Methacrylate Copolymer | 1One | |||||||
소듐아크릴레이트/아크릴로일다이메타트레이트/디메틸아크릴아마이드크로스폴리머Sodium acrylate / acryloyl dimethacrylate / dimethyl acrylamide cross polymer | 1One | |||||||
소듐아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머Sodium acrylate/sodium acryloyl dimethyl taurate copolymer | 1One | |||||||
소듐아크릴레이트/베헤네스-25메타크릴레이트크로스폴리머Sodium acrylate/Behenes-25 methacrylate crosspolymer | 1One | |||||||
유상부paid part | 에틸헥실메톡시신나메이트Ethylhexylmethoxycinnamate | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 |
디에틸아미노하이드록시벤조일헥실벤조에이트Diethylaminohydroxybenzoylhexylbenzoate | 44 | 44 | 44 | 44 | 44 | 44 | 44 | |
비스-에틸헥실옥시페놀메톡시페닐트리아진Bis-ethylhexyloxyphenol methoxyphenyltriazine | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
C12-15 알킬벤조에이트C12-15 Alkylbenzoate | 88 | 88 | 88 | 88 | 88 | 88 | 88 | |
티타늄디옥사이드titanium dioxide | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
사이클로펜타실록산Cyclopentasiloxane | 22 | 22 | 22 | 22 | 22 | 22 | 22 | |
디메치콘dimethicone | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
실리카silica | 1One | 1One | 1One | 1One | 1One | 1One | 1One | |
총합 |
100100 | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | |
in vitro SPF 변화율(%)In vitro SPF change (%) | 10.4910.49 | 11.2311.23 | 15.3215.32 | 8.688.68 | 16.716.7 | 20.2320.23 | 17.6817.68 |
원료명Raw material name | 비교예2Comparative Example 2 | 실시예15Example 15 | 실시예16Example 16 | 실시예17Example 17 | 실시예18Example 18 | 실시예19Example 19 | 실시예20Example 20 | 실시예21Example 21 | |
수상부Prime Minister | 정제수Purified water | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 | to 100to 100 |
글리세린glycerin | 1010 | ||||||||
디프로필렌글라이콜dipropylene glycol | 1010 | ||||||||
피이지-6PEG-6 | 1010 | ||||||||
피이지-8PEG-8 | 1010 | ||||||||
프로판디올propanediol | 1010 | 55 | |||||||
부틸렌글라이콜Butylene Glycol | 1010 | 55 | |||||||
폴리아크릴레이트-13Polyacrylate-13 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | |
하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | |
암모늄아크릴로일디메틸타우레이트/브이피코폴리머Ammonium acryloyl dimethyl taurate/vpicopolymer | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | |
유상부paid part | 에틸헥실메톡시신나메이트Ethylhexylmethoxycinnamate | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 |
디에틸아미노하이드록시벤조일헥실벤조에이트Diethylaminohydroxybenzoylhexylbenzoate | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | |
비스-에틸헥실옥시페놀메톡시페닐트리아진Bis-ethylhexyloxyphenol methoxyphenyltriazine | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
C12-15 알킬벤조에이트C12-15 Alkylbenzoate | 88 | 88 | 88 | 88 | 88 | 88 | 88 | 88 | |
티타늄디옥사이드titanium dioxide | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
사이클로펜타실록산Cyclopentasiloxane | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | |
디메치콘dimethicone | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |
실리카silica | 1One | 1One | 1One | 1One | 1One | 1One | 1One | 1One | |
종합 |
100100 | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | |
in vitro SPF 변화율(%)In vitro SPF change (%) | -12.74-12.74 | 1.671.67 | 16.6316.63 | 17.6117.61 | 34.4934.49 | 62.5562.55 | 137.3137.3 | 269.58269.58 |
글리세린glycerin | 디프로필렌글라이콜dipropylene glycol | 피이지-8PEG-8 | 피이지-6PEG-6 | 프로판디올propanediol | 부틸렌글라이콜Butylene Glycol |
프로판디올+ 부틸렌글라이콜propanediol+ Butylene Glycol |
|
상용성compatibility | 1One | 1.51.5 | 22 | 22 | 33 | 33 | 44 |
성분명Ingredient name | 실시예 22Example 22 | 실시예 23Example 23 | 실시예 24Example 24 | 실시예 25Example 25 | 실시예 26Example 26 | 실시예 27Example 27 | 실시예 28Example 28 | |
수상부Prime Minister | 정제수Purified water | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 |
부틸렌글라이콜Butylene Glycol | 66 | 66 | 66 | 66 | 66 | 66 | 66 | |
프로판디올propanediol | 55 | 55 | 55 | 55 | 55 | 55 | 55 | |
1,2-헥산디올1,2-Hexanediol | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | |
폴리소르베이트20 (Tween 20)Polysorbate 20 (Tween 20) | 1One | 22 | ||||||
글리세릴스테아레이트, 피이지-100스테아레이트 (Lipomulse 165)Glyceryl Stearate, PEG-100 Stearate (Lipomulse 165) | 1One | 22 | ||||||
폴리글리세릴-3메틸글루코오스디스테아레이트 (Tego care 450)Polyglyceryl-3 methylglucose distearate (Tego care 450) | 1One | 22 | ||||||
폴리아크릴레이트-13Polyacrylate-13 | 0.40.4 | 0.40.4 | 0.40.4 | 0.40.4 | 0.40.4 | 0.40.4 | 0.40.4 | |
하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | |
암모늄아크릴로일디메틸타우레이트/브이피코폴리머Ammonium acryloyl dimethyl taurate/vpicopolymer | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | |
유상부paid part | 에틸헥실메톡시신나메이트Ethylhexylmethoxycinnamate | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 |
디에틸아미노하이드록시벤조일헥실벤조에이트Diethylaminohydroxybenzoylhexylbenzoate | 44 | 44 | 44 | 44 | 44 | 44 | 44 | |
비스-에틸헥실옥시페놀메톡시페닐트리아진Bis-ethylhexyloxyphenol methoxyphenyltriazine | 44 | 44 | 44 | 44 | 44 | 44 | 44 | |
C12-15 알킬벤조에이트C12-15 Alkylbenzoate | 88 | 88 | 88 | 88 | 88 | 88 | 88 | |
티타늄디옥사이드titanium dioxide | 2.452.45 | 2.452.45 | 2.452.45 | 2.452.45 | 2.452.45 | 2.452.45 | 2.452.45 | |
알루미늄스테아레이트aluminum stearate | 0.420.42 | 0.420.42 | 0.420.42 | 0.420.42 | 0.420.42 | 0.420.42 | 0.420.42 | |
폴리하이드록시스테아릭애씨드polyhydroxystearic acid | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | |
알루미나alumina | 0.140.14 | 0.140.14 | 0.140.14 | 0.140.14 | 0.140.14 | 0.140.14 | 0.140.14 | |
사이클로펜타실록산Cyclopentasiloxane | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | |
실리카silica | 1One | 1One | 1One | 1One | 1One | 1One | 1One | |
디메치콘dimethicone | 22 | 22 | 22 | 22 | 22 | 22 | 22 | |
트리실록산Trisiloxane | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | 1.51.5 | |
총합total | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | 100100 | |
In vitro SPF 변화율 (%)In vitro SPF change (%) | 322322 | 134134 | 100100 | 172172 | 127127 | 4444 | 1212 |
성분명Ingredient name | 조성물1composition 1 | 조성물2composition 2 | 조성물3composition 3 | 조성물4composition 4 | 조성물5composition 5 | 조성물6composition 6 | |
수상부Prime Minister | 정제수Purified water | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 | To 100To 100 |
프로판디올propanediol | 55 | 55 | 55 | 55 | 55 | 55 | |
부틸렌글라이콜Butylene Glycol | 55 | 55 | 55 | 55 | 55 | 55 | |
하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머Hydroxyethyl acrylate/sodium acryloyl dimethyl taurate copolymer | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | 0.350.35 | |
폴리아크릴레이트크로스폴리머-6Polyacrylate crosspolymer-6 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | 0.20.2 | |
유상부paid part | 에틸헥실메톡시신나메이트Ethylhexylmethoxycinnamate | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 | 6.86.8 |
디에틸아미노하이드록시벤조일헥실벤조에이트Diethylaminohydroxybenzoylhexylbenzoate | 44 | 44 | 44 | 44 | 44 | 44 | |
비스-에틸헥실옥시페놀메톡시페닐트리아진Bis-ethylhexyloxyphenol methoxyphenyltriazine | 33 | 33 | 33 | 33 | 33 | 33 | |
C12-15 알킬벤조에이트C12-15 Alkylbenzoate | 88 | 88 | 88 | 88 | 88 | 88 | |
덱스트린 팔미테이트Dextrin Palmitate | 1One | ||||||
디스테아디모늄헥토라이트Disteadimonium Hectorite | 1One | ||||||
스테아로일 이눌린Stearoyl Inulin | 1One | ||||||
폴리아마이드-8Polyamide-8 | 1One | ||||||
글리세릴베헤네이트/에이코사디오에이트Glyceryl behenate/eicosadioate | 1One | ||||||
티타늄디옥사이드titanium dioxide | 33 | 33 | 33 | 33 | 33 | 33 | |
사이클로펜타실록산Cyclopentasiloxane | 22 | 22 | 22 | 22 | 22 | 22 | |
디메치콘dimethicone | 33 | 33 | 33 | 33 | 33 | 33 | |
실리카silica | 1One | 1One | 1One | 1One | 1One | 1One | |
총합 |
100100 | 100100 | 100100 | 100100 | 100100 | 100100 | |
In vitro SPF 변화율 (%)In vitro SPF change (%) | 82.2082.20 | 32.7832.78 | 20.8920.89 | 48.1648.16 | 14.6614.66 | 40.2140.21 |
In vitro SPF 변화율In vitro SPF rate of change | 온도Temperature | ||
25℃25℃ | 30℃30℃ | 40℃40℃ | |
자외선 조사 없음No UV irradiation | 2.132.13 | 18.6518.65 | 82.2082.20 |
2MED 조사2MED investigation | 5.005.00 | 25.225.2 | 115.71115.71 |
Claims (11)
- (a) 자가유화능을 갖는 폴리머 및 (b) IOB 값 5.0 이하의 다가알코올의 조합을 사용하여, 열에 의해 자외선 차단제의 자외선 차단 효율을 상승시키는 방법.A method of increasing the UV protection efficiency of a UV blocker by heat using a combination of (a) a polymer having self-emulsifying ability and (b) a polyhydric alcohol having an IOB value of 5.0 or less.
- 제1항에 있어서, 상기 방법은 The method of claim 1, wherein the method상기 자가유화능을 갖는 폴리머 및 상기 다가알코올을 포함하는 수상부를 준비하는 단계;preparing an aqueous phase comprising the polymer having the self-emulsifying ability and the polyhydric alcohol;상기 자외선 차단제를 포함하는 유상부를 준비하는 단계;preparing an oil phase containing the sunscreen;상기 수상부 및 유상부를 혼합하여 혼합 조성물을 제조하는 단계; 및mixing the aqueous phase part and the oil phase part to prepare a mixed composition; and상기 혼합 조성물에 열을 가하는 단계applying heat to the mixture composition를 포함하는 것을 특징으로 하는 방법.A method comprising a.
- (a) 자가유화능을 갖는 폴리머 및 (b) IOB 값 5.0 이하의 다가알코올의 조합을 유효성분으로 포함하는, 열에 의해 자외선 차단제의 자외선 차단 효율을 상승시키기 위한 조성물.(a) a polymer having self-emulsifying ability and (b) an IOB value of 5.0 or less polyalcohol as an active ingredient, comprising as an active ingredient, a composition for increasing the UV protection efficiency of a UV blocker by heat.
- 제3항에 있어서, 열에 의해 자외선 차단제의 자외선 차단 효율을 상승시키기는 역할을 하는 상기 유효성분은 (a) 자가유화능을 갖는 폴리머 및 (b) IOB 값 5.0 이하의 다가알코올의 조합으로 이루어진 것을 특징으로 하는 조성물.The method according to claim 3, wherein the active ingredient, which serves to increase the UV blocking efficiency of the UV blocker by heat, is composed of a combination of (a) a self-emulsifying polymer and (b) a polyhydric alcohol having an IOB value of 5.0 or less. Characterized composition.
- 제3항에 있어서, 상기 자가유화능을 갖는 폴리머는 소듐아크릴레이트/베헤네스-25메타크릴레이트크로스폴리머, 소듐아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머, 소듐아크릴레이트/아크릴로일다이메타트레이트/디메틸아크릴아마이드크로스폴리머, 소듐폴리아크릴레이트, 아크릴레이트/C10-30알킬아크릴레이트크로스폴리머, 아크릴레이트/베헤네스-25메타크릴레이트코폴리머, 아크릴레이트코폴리머, 암모늄아크릴로일디메틸타우레이트/베헤네스-25메타크릴레이트크로스폴리머, 암모늄아크릴로일디메틸타우레이트/브이피코폴리머, 폴리아크릴레이트-13, 폴리아크릴레이트크로스폴리머-6, 폴리아크릴아마이드, 피이지-240/에이치디아이코폴리머비스-데실테트라데세스-20에터, 및 하이드록시에틸아크릴레이트/소듐아크릴로일디메틸타우레이트코폴리머로 이루어진 군으로부터 선택되는 1 이상인 것을 특징으로 하는 조성물.According to claim 3, wherein the self-emulsifying polymer is sodium acrylate / Behenes-25 methacrylate cross polymer, sodium acrylate / sodium acryloyl dimethyl taurate copolymer, sodium acrylate / acryloyl die Methrate/dimethylacrylamide crosspolymer, sodium polyacrylate, acrylate/C10-30 alkyl acrylate crosspolymer, acrylate/behenes-25 methacrylate copolymer, acrylate copolymer, ammonium acryloyldimethyl Taurate/Behenes-25methacrylate crosspolymer, ammonium acryloyldimethyltaurate/vpicopolymer, polyacrylate-13, polyacrylate crosspolymer-6, polyacrylamide, PG-240/HDI A composition, characterized in that at least one selected from the group consisting of copolymer bis-decyltetradeceth-20 ether, and hydroxyethyl acrylate/sodium acryloyldimethyltaurate copolymer.
- 제3항에 있어서, 상기 IOB 값 5.0 이하의 다가알코올은 글리세린, 솔비톨, 자일리톨, 글루코스, 트레할로스, 디글리세린, 프로판디올, 프로필렌글라이콜, 폴리글리세린-3, 메틸프로판디올, 부틸렌글라이콜, 펜틸렌글라이콜, 피이지-6, 피이지-8, 글리세레스-26, 디프로필렌글라이콜, 1,2-헥산디올 및 카프릴릴글라이콜로 이루어진 군으로부터 선택되는 1 이상인 것을 특징으로 하는 조성물.The method of claim 3, wherein the polyhydric alcohol having an IOB value of 5.0 or less is glycerin, sorbitol, xylitol, glucose, trehalose, diglycerin, propanediol, propylene glycol, polyglycerin-3, methylpropanediol, butylene glycol, Composition, characterized in that at least one selected from the group consisting of pentylene glycol, PEG-6, PEG-8, glycereth-26, dipropylene glycol, 1,2-hexanediol and caprylyl glycol .
- 제3항에 있어서, 상기 자외선 차단제는 아미노벤조산(aminobenzoic acid)계 화합물, 벤조페논(benzophenone)계 화합물, 신나메이트(cinnamate)계 화합물, 살리실레이트(salicylate)계 화합물, 무기산화금속(inorganic metal oxides), 부틸메톡시디벤조일메탄(butyl methoxydibenzoylmethane), 테레프탈릴리덴 디캠퍼 설폰산(terephthalylidene dicamphor sulfonic acid) 에캄슐(ecamsule), 페닐벤지미다졸설포닉애씨드(phenylbenzimidazole sulfonic acid), 베모트리지놀(bemotrizinol) 및 비스옥트리졸(bisoctrizole)로 이루어진 군으로부터 선택되는 1 이상인 것을 특징으로 하는 조성물.The method of claim 3, wherein the sunscreen is an aminobenzoic acid-based compound, a benzophenone-based compound, a cinnamate-based compound, a salicylate-based compound, or an inorganic metal oxide. oxides), butyl methoxydibenzoylmethane, terephthalylidene dicamphor sulfonic acid, ecamsule, phenylbenzimidazole sulfonic acid, bemotrizinol and at least one selected from the group consisting of bisoctrizole.
- 제3항에 있어서, 상기 자가유화능을 갖는 폴리머는 수상 증점제인 것을 특징으로 하는 조성물.The composition according to claim 3, wherein the self-emulsifying polymer is an aqueous phase thickener.
- 제3항에 있어서, 상기 조성물은 수상부 및 유상부를 포함하고, (a) 자가유화능을 갖는 폴리머 및 (b) IOB 값 5.0 이하의 다가알코올은 상기 수상부에 포함되며, 상기 자외선 차단제는 유상부에 포함되는 것을 특징으로 하는 조성물.The method according to claim 3, wherein the composition includes an aqueous phase and an oil phase, (a) a polymer having self-emulsifying ability and (b) a polyalcohol having an IOB value of 5.0 or less is included in the aqueous phase, and the sunscreen is an oil phase Composition characterized in that it is included in the.
- 제 3항에 있어서, 상기 조성물은 자외선 조사 시, 열에 의해 자외선 차단제의 자외선 차단 효율의 상승효과가 더 증가하는 것을 특징으로 하는 조성물. The composition according to claim 3, wherein the composition further increases the synergistic effect of the UV blocking efficiency of the UV blocker by heat when irradiated with UV rays.
- 제3항 내지 제10항 중 어느 하나의 항에 따른 조성물을 포함하는 화장품.A cosmetic comprising the composition according to any one of claims 3 to 10.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180037957.1A CN115697296B (en) | 2020-06-03 | 2021-05-24 | Cosmetic composition for blocking ultraviolet rays, which has improved ultraviolet ray blocking efficiency by heat and ultraviolet rays |
JP2022574823A JP2023528506A (en) | 2020-06-03 | 2021-05-24 | A cosmetic composition for blocking ultraviolet rays, in which the efficiency of blocking ultraviolet rays is increased by heat and ultraviolet rays |
US18/000,821 US20230248634A1 (en) | 2020-06-03 | 2021-05-24 | Uv-blocking cosmetic composition having increased uv-blocking efficiency due to heat and uv light |
CN202311566696.XA CN117357434A (en) | 2020-06-03 | 2021-05-24 | Method for improving ultraviolet blocking efficiency and cosmetic manufacturing application |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0067122 | 2020-06-03 | ||
KR20200067122 | 2020-06-03 | ||
KR1020200166725A KR102313519B1 (en) | 2020-06-03 | 2020-12-02 | UV-blocking cosmetic composition that increases UV blocking efficiency by heat and UV light |
KR10-2020-0166725 | 2020-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021246704A1 true WO2021246704A1 (en) | 2021-12-09 |
Family
ID=78150876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/006456 WO2021246704A1 (en) | 2020-06-03 | 2021-05-24 | Uv-blocking cosmetic composition having increased uv-blocking efficiency due to heat and uv light |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230248634A1 (en) |
JP (1) | JP2023528506A (en) |
KR (2) | KR102313519B1 (en) |
CN (2) | CN117357434A (en) |
TW (1) | TW202210058A (en) |
WO (1) | WO2021246704A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102556558B1 (en) * | 2022-07-28 | 2023-07-19 | 한국콜마주식회사 | Emulsion type cosmetic composition comprising self-emulsifying inducer and self-emulsifying stabilizer |
KR102556559B1 (en) * | 2022-07-28 | 2023-07-19 | 한국콜마주식회사 | Self-emulsifying emulsion type cosmetic composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120112849A (en) * | 2010-02-04 | 2012-10-11 | 아이에스피이 인베스트먼츠 인코포레이팃드 | Self adapting polymers for anhydrous sunscreen formulations |
KR20130026209A (en) * | 2011-09-05 | 2013-03-13 | 한국콜마주식회사 | Cosmetic composition for sun protection |
KR20190038028A (en) * | 2017-09-29 | 2019-04-08 | 코스맥스 주식회사 | Oil in Water Type Macro Emulsion Cosmetic Composition for UV Protection |
KR20190059663A (en) * | 2017-11-23 | 2019-05-31 | 코스맥스 주식회사 | Oil-in-water type cosmetic composition for UV protection with water resistance |
KR20200010956A (en) * | 2018-07-23 | 2020-01-31 | 주식회사 초이스엔텍 | Cosmetic composition for sunscreen containing ethanol |
KR20200055589A (en) * | 2018-11-13 | 2020-05-21 | 코스맥스 주식회사 | UV protection cosmetic composition comprising waterborne polyurethane |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101250074B1 (en) * | 2011-02-07 | 2013-04-03 | 한국콜마주식회사 | UV protecting cosmetic composite with no emulsifiers |
KR101388641B1 (en) * | 2012-08-24 | 2014-04-24 | 한국콜마주식회사 | Oil-in-water type of semi-transparent cosmetic composition for blocking ultraviolet |
KR20170061898A (en) * | 2015-11-27 | 2017-06-07 | 코웨이 주식회사 | Oil in Water Emulsion Sunscreen Cosmetic Composition |
CN112533586A (en) * | 2018-08-10 | 2021-03-19 | 株式会社资生堂 | Emulsified cosmetic |
EP3834812A4 (en) * | 2018-08-10 | 2022-05-04 | Shiseido Company, Ltd. | Cosmetic product |
US20210338544A1 (en) * | 2018-08-10 | 2021-11-04 | Shiseido Company, Ltd. | Emulsion cosmetic |
WO2020032246A1 (en) * | 2018-08-10 | 2020-02-13 | 株式会社 資生堂 | Sunscreen effect enhancer |
KR102026658B1 (en) | 2019-02-27 | 2019-09-30 | 주식회사 엘지생활건강 | A Sunscreen Cosmetic Formulation with Increased UV absorption efficiency by UV light |
CN109820738B (en) * | 2019-03-29 | 2021-11-02 | 广东芭薇生物科技股份有限公司 | High-power oil-in-water sunscreen cosmetic |
-
2020
- 2020-12-02 KR KR1020200166725A patent/KR102313519B1/en active IP Right Grant
-
2021
- 2021-05-24 WO PCT/KR2021/006456 patent/WO2021246704A1/en active Application Filing
- 2021-05-24 CN CN202311566696.XA patent/CN117357434A/en active Pending
- 2021-05-24 US US18/000,821 patent/US20230248634A1/en active Pending
- 2021-05-24 CN CN202180037957.1A patent/CN115697296B/en active Active
- 2021-05-24 KR KR1020210066480A patent/KR20210150284A/en active Search and Examination
- 2021-05-24 JP JP2022574823A patent/JP2023528506A/en active Pending
- 2021-06-02 TW TW110120078A patent/TW202210058A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120112849A (en) * | 2010-02-04 | 2012-10-11 | 아이에스피이 인베스트먼츠 인코포레이팃드 | Self adapting polymers for anhydrous sunscreen formulations |
KR20130026209A (en) * | 2011-09-05 | 2013-03-13 | 한국콜마주식회사 | Cosmetic composition for sun protection |
KR20190038028A (en) * | 2017-09-29 | 2019-04-08 | 코스맥스 주식회사 | Oil in Water Type Macro Emulsion Cosmetic Composition for UV Protection |
KR20190059663A (en) * | 2017-11-23 | 2019-05-31 | 코스맥스 주식회사 | Oil-in-water type cosmetic composition for UV protection with water resistance |
KR20200010956A (en) * | 2018-07-23 | 2020-01-31 | 주식회사 초이스엔텍 | Cosmetic composition for sunscreen containing ethanol |
KR20200055589A (en) * | 2018-11-13 | 2020-05-21 | 코스맥스 주식회사 | UV protection cosmetic composition comprising waterborne polyurethane |
Also Published As
Publication number | Publication date |
---|---|
TW202210058A (en) | 2022-03-16 |
US20230248634A1 (en) | 2023-08-10 |
KR20210150284A (en) | 2021-12-10 |
CN115697296B (en) | 2023-12-22 |
CN115697296A (en) | 2023-02-03 |
KR102313519B1 (en) | 2021-10-15 |
JP2023528506A (en) | 2023-07-04 |
CN117357434A (en) | 2024-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5849273A (en) | Skin care and sunscreen composition containing dibenzoylmethane derivative, e.g., parsol® 1789, and C12, C16, C18 branched chain hydroxybenzoate and/or C12, C16 branched chain benzoate stabilizers/solubilizers | |
DE60029672T2 (en) | Photostable cosmetic sunscreen | |
EP2505183B1 (en) | O/w emulsion cosmetic | |
WO2021246704A1 (en) | Uv-blocking cosmetic composition having increased uv-blocking efficiency due to heat and uv light | |
EP2194958B1 (en) | Sunless tanning composition with photostabilized sunscreen | |
KR102026658B1 (en) | A Sunscreen Cosmetic Formulation with Increased UV absorption efficiency by UV light | |
JPH02121915A (en) | Waterproofing cream conditioner | |
EP2674146A1 (en) | Sunscreen cosmetic | |
KR20120042397A (en) | Water-in-oil type cosmetic composition for blocking ultraviolet containing a large amount of silicone elastomer | |
WO2019004596A1 (en) | Transparent cosmetic composition having ultraviolet screening function | |
EP2777690B1 (en) | Oil-in-water type emulsified sunscreen cosmetic | |
KR102451738B1 (en) | Cosmetic composition for sunscreen comprising polysaccharide thickener and method for preparing same | |
KR20160094341A (en) | UV block cosmetic composition comprising high inorganic uv absorbers | |
CN113730269A (en) | Mild gel with sun-screening effect and preparation method thereof | |
WO2016114466A1 (en) | Cosmetic product comprising water-insoluble sponge impregnated with cosmetic composition having ultraviolet ray blocking function | |
ES2218637T3 (en) | COMPOSITION FOR CUTANEOUS PROTECTION AND ADMINISTRATION OF VITAMINS. | |
DE102010063894A1 (en) | High silicone oil cosmetic or dermatological sunscreens comprising a combination of polyacrylate and polyacrylamide thickener | |
KR101572220B1 (en) | Sun block cosmetics composition having water resistance and easy washability together | |
KR20170054238A (en) | UV protecting cosmetic compositions of O/W type having excellent water resistant property | |
WO2012084603A2 (en) | Cosmetic or dermatological uv protection preparations comprising a combination of polyacylate and polyacrylamide thickener | |
KR102073635B1 (en) | Cosmetic composition for sunscreen containing ethanol | |
CN105997577B (en) | Gel-like oil-in-water type cosmetic | |
WO2019098637A2 (en) | Water-in-silicone type cosmetic composition comprising organic sunscreen agent | |
KR102419912B1 (en) | Mist type sunscreen cosmetic composition | |
KR20130109653A (en) | Uv screening compositions and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21817524 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022574823 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC. EPO FORM 1205A DATED12.05.2023. |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21817524 Country of ref document: EP Kind code of ref document: A1 |